CD44 and cancer: Mechanisms involved include activation of the MAP kinase pathways through CD74 and CD44 (Shi et al, 2006), suppression of p53 (Hudson et al, 1999; Fingerle-Rowson et al, 2003) and downregulation of NKG2D enhancing immune evasion by cancer cells (Krockenberger et al, 2008).